Skip to main content
Equibles

HRT FINANCIAL LP

Position in OCGN — Ocugen, Inc.

CIK 1475597 NEW YORK, NY
Back to OCGN Full portfolio

Position in OCGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,705,494
+$2,023,859 QoQ
Shares Held
1,768,297
+369.5% QoQ
Ownership
0.521%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#18
of 147 holders
Holding Since
Dec 2020
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in OCGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

HRT FINANCIAL LP holds $857,639,414 across 185 Biotechnology names. OCGN ranks #49 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BBIO
BridgeBio Pharma, Inc.
 1,089,376 $81,136,724
2 INSM
INSMED Inc
 689,981 $73,565,774
3 EXEL
Exelixis, Inc.
 929,242 $50,560,057
4 MDGL
Madrigal Pharmaceuticals, Inc.
 84,634 $45,444,226
5 AXSM
Axsome Therapeutics, Inc.
 178,491 $43,689,242
6 ARWR
Arrowhead Pharmaceuticals, Inc.
 498,655 $40,645,369
7 ABVX
Abivax S.A.
 270,612 $36,061,755
8 TGTX
Tg Therapeutics, Inc.
 622,603 $34,205,808

All Filings in OCGN

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,705,494 1,768,297
2026-03-31 $681,635 376,594
2025-09-30 $610,457 374,514
2025-06-30 $250,078 257,813
2024-12-31 $139,566 173,375
2024-03-31 $1,322,660 806,500
2023-06-30 $136,399 251,196
2023-03-31 $859,591 1,007,728
2022-09-30 $557,303 313,092
2021-12-31 $165,861 36,453
2021-03-31 $3,876,119 570,857
2020-12-31 $20,821 11,378